Axxcess Wealth Management LLC Buys 107,179 Shares of Cencora, Inc. $COR

Axxcess Wealth Management LLC raised its holdings in shares of Cencora, Inc. (NYSE:COR) by 1,086.1% during the fourth quarter, Holdings Channel.com reports. The fund owned 117,047 shares of the company’s stock after buying an additional 107,179 shares during the period. Axxcess Wealth Management LLC’s holdings in Cencora were worth $39,533,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of the business. Vestcor Inc raised its holdings in Cencora by 0.5% during the third quarter. Vestcor Inc now owns 5,196 shares of the company’s stock valued at $1,624,000 after acquiring an additional 28 shares during the period. JFS Wealth Advisors LLC raised its holdings in Cencora by 30.2% during the fourth quarter. JFS Wealth Advisors LLC now owns 125 shares of the company’s stock valued at $42,000 after acquiring an additional 29 shares during the period. Cornerstone Wealth Group LLC raised its holdings in Cencora by 1.3% during the third quarter. Cornerstone Wealth Group LLC now owns 2,383 shares of the company’s stock valued at $745,000 after acquiring an additional 30 shares during the period. Apollon Wealth Management LLC raised its holdings in Cencora by 0.5% during the fourth quarter. Apollon Wealth Management LLC now owns 6,527 shares of the company’s stock valued at $2,205,000 after acquiring an additional 30 shares during the period. Finally, Vermillion & White Wealth Management Group LLC raised its holdings in Cencora by 31.4% during the third quarter. Vermillion & White Wealth Management Group LLC now owns 138 shares of the company’s stock valued at $43,000 after acquiring an additional 33 shares during the period. 97.52% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of research firms have commented on COR. Barclays raised their price target on Cencora from $400.00 to $425.00 and gave the company an “overweight” rating in a report on Friday, February 13th. Robert W. Baird decreased their target price on Cencora from $420.00 to $339.00 and set an “outperform” rating on the stock in a research report on Thursday, May 7th. Evercore set a $360.00 target price on Cencora in a research report on Wednesday, April 8th. Citigroup decreased their target price on Cencora from $405.00 to $355.00 and set a “buy” rating on the stock in a research report on Thursday, May 7th. Finally, UBS Group boosted their target price on Cencora from $410.00 to $412.00 and gave the stock a “buy” rating in a research report on Thursday, May 7th. Twelve investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $380.25.

Cencora Trading Up 0.2%

COR opened at $265.37 on Friday. The firm has a market cap of $51.63 billion, a P/E ratio of 20.35, a P/E/G ratio of 1.22 and a beta of 0.64. Cencora, Inc. has a 12 month low of $244.82 and a 12 month high of $377.54. The company has a current ratio of 0.95, a quick ratio of 0.59 and a debt-to-equity ratio of 3.40. The stock has a 50-day moving average of $307.20 and a 200 day moving average of $337.20.

Cencora (NYSE:COR) last released its quarterly earnings results on Wednesday, May 6th. The company reported $4.75 EPS for the quarter, missing the consensus estimate of $4.82 by ($0.07). The company had revenue of $78.36 billion during the quarter, compared to analysts’ expectations of $81.09 billion. Cencora had a return on equity of 135.20% and a net margin of 0.78%.The company’s revenue was up 3.9% on a year-over-year basis. During the same quarter in the prior year, the business posted $4.42 EPS. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. As a group, research analysts forecast that Cencora, Inc. will post 17.76 EPS for the current year.

Cencora declared that its Board of Directors has initiated a stock buyback plan on Thursday, May 21st that allows the company to buyback $2.00 billion in shares. This buyback authorization allows the company to reacquire up to 3.9% of its stock through open market purchases. Stock buyback plans are usually a sign that the company’s board of directors believes its shares are undervalued.

Cencora Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, June 1st. Shareholders of record on Friday, May 15th will be given a dividend of $0.60 per share. This represents a $2.40 annualized dividend and a dividend yield of 0.9%. The ex-dividend date is Friday, May 15th. Cencora’s payout ratio is 18.40%.

Cencora Profile

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.